Baronsmead Venture Trust (BVT) Share Price, News & Analysis

Company Overview

Baronsmead Venture Trust Plc is a venture capital trust managed by ISIS Equity Partners LLP. It invests in a portfolio of unquoted companies in the United Kingdom, which raise expansion capital or are the subject of a management buy-out or buy-in. The trust primarily invests in the media, business services, consumer, information technology support services, and healthcare sectors. It also invests in companies raising new share capital on the Alternative Investment Market.

Key Stats

• Today's Range: 47.80 to 47.80
• 50-Day Range: 46.80 to 49.80
• 52-Week Range: 40 to 56
• Volume: N/A
• Average Volume: 105,555 shs
• Market Capitalization: £185.54 million
• P/E Ratio: 13.98
• Dividend Yield: 8.37%
• Price Target: N/A
• Consensus Rating: N/A

BVT Stock Analysis - Frequently Asked Questions

How have BVT shares performed this year?

Baronsmead Venture Trust's stock was trading at GBX 52 at the beginning of the year. Since then, BVT shares have decreased by 8.1% and is now trading at GBX 47.80.
View the best growth stocks for 2025 here.

How were Baronsmead Venture Trust's earnings last quarter?

Baronsmead Venture Trust Plc (LON:BVT) posted its quarterly earnings results on Tuesday, December, 24th. The company reported $0.53 earnings per share for the quarter. Baronsmead Venture Trust had a trailing twelve-month return on equity of 6.22% and a net margin of 75.56%.

How do I buy shares of Baronsmead Venture Trust?

Shares of BVT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Baronsmead Venture Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Baronsmead Venture Trust investors own include Teva Pharmaceutical Industries (TEVA) and BP (BP).

Company Calendar

• Last Earnings: 12/24/2024
• Record date for 3/17 Dividend: 2/13/2025
• Ex-Dividend for 3/17 Dividend: 2/13/2025
• Dividend Payable: 3/17/2025
• Today: 5/29/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:BVT
• CIK: N/A
• Web: www.baronsmeadvcts.co.uk
• Phone: +44-20-75065600
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX 3.42
• Trailing P/E Ratio: 13.98
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £13.28 million
• Net Margins: 75.56%
• Pretax Margin: N/A
• Return on Equity: 6.22%
• Return on Assets: 1.39%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: 31.18

Sales & Book Value

• Annual Sales: £17.57 million
• Price / Sales: 10.56
• Cash Flow: GBX 9.15 per share
• Price / Cash Flow: 5.23
• Book Value: GBX 54.59 per share
• Price / Book: 0.88

Miscellaneous

• Outstanding Shares: 388,165,000
• Free Float: N/A
• Market Cap: £185.54 million
• Optionable: Not Optionable
• Beta: 0.19